Dr Daniel Lindsay

Senior Research Fellow, Cancer Health Economics, Group Lead
What inspires me

The discovery of new knowledge through research excellence and the ability to implement research findings into cancer policy, practice and service delivery.

Profile information

Areas of expertise

Health economics, biostatistics, skin cancer

Overview

Dr Daniel Lindsay is a Senior Research Fellow and Cancer Health Economics Group Lead within the Viertel Cancer Research Centre. Dr Lindsay has a background in psychology, with extensive knowledge and experience in health economics, biostatistics and quantitative research methods. His research focuses on evaluating the cost-effectiveness of health interventions in cancer care, assessing the financial burden of cancer survivors and assessing inequities in costs and cancer care. Dr Lindsay has a specific interest in the health economics of skin cancer, including primary and secondary prevention, but has worked across all types of cancer. Dr Lindsay is driven by the practical application and implementation of his research findings to support policy, service delivery and clinical practice.

Education

PhD (Psychology)

BPsych. (Hons) 

Get to know Dr Daniel Lindsay

How does your research contribute to the bigger picture in cancer prevention, treatment, and support?

My current role as Senior Research Fellow, Cancer Health Economics allows me to evaluate the cost-effectiveness of health interventions in cancer prevention, screening, treatment and supportive care. The financial aspects of cancer care are becomingly increasingly important in an ageing population and resource-constrained healthcare system. Working closely with clinicians, key stakeholders and consumers, my work builds on clinical evidence to provide additional financial insights for the wider implementation of novel cancer interventions and models of care.

What’s your ‘connection to cause’, and what inspires you to keep going, especially through complex challenges?

It is almost impossible to find someone not impacted by cancer in Australia, so the ability to conduct quality cancer-related research that can potentially contribute to increased cancer prevention and/or improve patient outcomes is a real privilege.

What recent breakthroughs or advances in cancer research are you most excited about?

While I still feel like there is a way to go in this space, watching the continual development and integration of artificial intelligence into healthcare is exciting. There are endless opportunities for AI to improve healthcare delivery and efficiency and I am excited to see what further developments arise in the future.